These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23170779)

  • 21. Drug regulators and ethics: which GCP issues are also ethical issues?
    Bernabe RD; van Thiel GJ; Breekveldt NS; van Delden JJ
    Drug Discov Today; 2016 Feb; 21(2):217-24. PubMed ID: 26610417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Industry perspectives on ICH guidelines.
    Rockhold FW
    Stat Med; 2002 Oct; 21(19):2949-57. PubMed ID: 12325111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In order to perform clinical trials efficiently in Japan--important issues regarding monitoring by sponsors].
    Kaichi S; Oda T; Goto K; Sato K
    Nihon Kokyuki Gakkai Zasshi; 2007 Nov; 45(11):829-35. PubMed ID: 18051783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites.
    Zon R; Meropol NJ; Catalano RB; Schilsky RL
    J Clin Oncol; 2008 May; 26(15):2562-7. PubMed ID: 18390967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is ICH exportable outside the European Union?
    Dent NJ
    Qual Assur; 2000; 8(1):19-31. PubMed ID: 11710304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GCP data quality for early clinical development.
    Rock EP; Molloy VJ; Humphrey JS
    Clin Cancer Res; 2010 Mar; 16(6):1756-63. PubMed ID: 20215550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Development of anti-cancer drugs under new renewed GCP--from the viewpoint of drug development company developer].
    Ueno T; Kobayashi T; Inoue K; Yanagi Y; Yamada Y
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):663-70. PubMed ID: 9571963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statistical concepts in the planning and evaluation of drug safety from clinical trials in drug development: issues of international harmonization.
    O'Neill RT
    Stat Med; 1995 May 15-30; 14(9-10):117-27. PubMed ID: 7569506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical trials in developing countries: who should define ethics?].
    Béréterbide F; Hirsch F
    Bull Soc Pathol Exot; 2008 Apr; 101(2):102-5. PubMed ID: 18543701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The role of ethical committees in drug trials performed according to "Good Clinical Practice"].
    Kerpel-Fronius S
    Orv Hetil; 1991 Mar; 132(13):703-5. PubMed ID: 2014128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Performing clinical trials efficiently in Japan--independent clinical trials and GCP].
    Kanai M; Suzuki-Nishimura T
    Nihon Kokyuki Gakkai Zasshi; 2007 Jun; 45(6):449-54. PubMed ID: 17644939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Good clinical practice (GCP)].
    Hvidberg E; Dirach J
    Theriaca; 1998 Sep; 31():7-53. PubMed ID: 11625363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role and responsibilities of witnesses in the informed consent process.
    Angeles-Llerenas AR; Wirtz V; Lara-Alvarez CF
    Dev World Bioeth; 2009 Apr; 9(1):18-25. PubMed ID: 18370932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time for new rules on human subjects research?
    Dresser R
    Hastings Cent Rep; 1998; 28(6):23-4. PubMed ID: 9868606
    [No Abstract]   [Full Text] [Related]  

  • 35. Review of national research ethics regulations and guidelines in Middle Eastern Arab countries.
    Alahmad G; Al-Jumah M; Dierickx K
    BMC Med Ethics; 2012 Dec; 13():34. PubMed ID: 23234422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes to ICH guideline M3: new and revised guidance on nonclinical safety studies to support human clinical trials and marketing authorization.
    Ledwith BJ; DeGeorge JJ
    Clin Pharmacol Ther; 2011 Feb; 89(2):295-9. PubMed ID: 21178992
    [No Abstract]   [Full Text] [Related]  

  • 37. Harmonizing regulations for biomedical research: a critical analysis of the US and Venezuelan systems.
    Di Tillio-Gonzalez D; Fischbach RL
    Dev World Bioeth; 2008 Dec; 8(3):167-77. PubMed ID: 17488491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statistical principles for clinical trials (ICH E9): an introductory note on an international guideline.
    Lewis JA
    Stat Med; 1999 Aug; 18(15):1903-42. PubMed ID: 10440877
    [No Abstract]   [Full Text] [Related]  

  • 39. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Implementation of new Japanese GCP and the quality of clinical trials--from the standpoint of the pharmaceutical industry].
    Ebi O
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):1883-91. PubMed ID: 9350232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.